IP Library Granted Patent US 7,456,281
Granted Patent B2
US 7,456,281 · App. 11/485,851 · Granted Nov 25, 2008

Nucleic acid melting analysis with saturation dyes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,456,281
App. No.
11/485,851
Granted
Nov 25, 2008
Kind
B2
Abstract

Methods are provided for nucleic acid analysis wherein a target nucleic acid is mixed with a dsDNA binding dye to form a mixture. Optionally, an unlabeled probe is included in the mixture. A melting curve is generated for the target nucleic acid by measuring fluorescence from the dsDNA binding dye as the mixture is heated. Dyes for use in nucleic acid analysis and methods for making dyes are also provided.

Claims (158)

1. A compound having the formula:

wherein

the moiety  represents an optionally-substituted fused monocyclic or polycyclic aromatic ring or an optionally-substituted fused monocyclic or polycyclic nitrogen-containing heteroaromatic ring;

X is oxygen, sulfur, selenium, tellurium or a moiety selected from C(CH 3 ) 2 and NR 1 , where R 1 is hydrogen or C 1-6 alkyl;

R 2 is selected from the group consisting of C 1-6 alkyl, C 3-8 cycloalkyl, aryl, aryl(C 1-3 alkyl), hydroxyalkyl, alkoxyalkyl, aminoalkyl, mono and dialkylaminoalkyl, trialkylammoniumalkyl, alkylenecarboxylate, alkylenecarboxamide, alkylenesulfonate, optionally substituted cyclic heteroatom-containing moieties, and optionally substituted acyclic heteroatom-containing moieties;

t=0 or 1;

Z is a charge selected from 0 or 1;

R 3 is selected from the group consisting of hydrogen, C 1-6 alkyl, and arylcarbonyl, or R 2 and R 3 are taken together to form —CH 2 ) w —, wherein w is 1 to 5;

R 9 and R 10 are each independently selected from the group consisting of hydrogen, C 1-6 alkyl, and arylcarbonyl;

n=0, 1, or 2; and

v=0 or 1; with the proviso that v=0 when R 2 and R 3 are not taken together to form —(CH 2 ) w —;

wherein when v=0, Q is an heterocycle selected from the group of structures consisting of:

and

wherein when v=1, Q is an heterocycle selected from the group of structures consisting of:

wherein R 4 , R 5 , R 6 , R 7 , R 8 , R 12 , and R 13 are independently selected from the group consisting of hydrogen, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, alkenyl, polyalkenyl, alkynyl, polyalkynyl, alkenylalkynyl, alkylnitrilethio, aryl, heteroaryl, alkoxy, arylcarbonylthio, cycloheteroalkylcarbonylthio, dialkylaminoalkylcarbonylthio, dialkylamino, cycloalkylthio, cycloheteroalkylthio, trialkylammoniumalkylthio, trialkylammoniumalkylcarbonylthio, and nucleosidylthio, each of which may be optionally substituted; an acyclic heteroatom-containing moiety, a cyclic heteroatom-containing moiety, a BRIDGE-DYE, and a reactive group, each of which optionally includes a quaternary ammonium moiety.

2. The compound of claim 1 , wherein at least one of R 4 , R 5 , R 6 , R 7 , and R 8 is selected from the group consisting of arylcarbonylthio, cycloheteroalkylcarbonylthio, dialkylaminoalkylcarbonylthio, trialkylammoniumalkylcarbonylthio, alkylnitrilethio, cycloalkylthio, cycloheteroalkylthio, trialkylammoniumalkylthio, and nucleosidylthio, each of which may be optionally substituted.

3. The compound of claim 2 , wherein R 4 is optionally substituted arylcarbonylthio and is selected from the group consisting of 4-(carbonylthio)-pyridinyl, 4-(carbonylthio)-nitrophenyl, 4-(carbonylthio)-phenyl, 4-(carbonylthio)-N,N-dimethylanilinyl, 2-(carbonylthio)-pyrazinyl, 6-(carbonylthio)-benzopyrazinyl, 5-(carbonylthio)-1-methyl-1,2,3-benzotriazolyl, and carbonylthio-pentafluorophenyl.

4. The compound of claim 2 , wherein R 4 is optionally substituted cycloheteroalkylcarbonylthio and is selected from the group consisting of 4-(carbonylthio)-N-methylpiperazinyl, 4-(carbonylthio)-N,N-dimethylpiperazinium, and 4-(carbonylthio)-morpholinyl.

5. The compound of claim 2 , wherein R 4 is the optionally substituted dialkylaminoalkylcarbonylthio group N,N-dimethylaminomethylcarbonylthio.

6. The compound of claim 2 , wherein R 4 is the optionally substituted trialkylammoniumalkylcarbonylthio group trimethylammoniummethylcarbonylthio.

7. The compound of claim 2 , wherein R 4 is the optionally substituted alkylnitrilethio group acetonitrilethio.

8. The compound of claim 2 , wherein R 4 is the optionally substituted cycloalkylthio group 1-(thio)-bicyclo[2.2.1]heptyl.

9. The compound of claim 2 , wherein R 4 is the optionally substituted cycloheteroalkylthio group 4-(thio)-N-methylpiperadinyl.

10. The compound of claim 2 , wherein R 4 is the optionally substituted trialkylammoniumalkylthio group trimethylammoniumpropylthio.

11. The compound of claim 2 , wherein R 4 is the optionally substituted nucleosidylthio group 5′-deoxy-adenosinyl-thio.

12. The compound of claim 2 , having the formula:

13. The compound of claim 1 , wherein at least one of R 4 , R 5 , R 6 , R 7 , and R 8 is selected from the group consisting of 4-(carbonylthio)-pyridinyl, 4-(carbonylthio)-nitrophenyl, 4-(carbonylthio)-phenyl, 4-(carbonylthio),N,N-dimethylanilinyl, 2-(carbonylthio)-pyrazinyl, 6-(carbonylthio)-benzopyrazinyl, 5-(carbonylthio)-1-methyl-1,2,3-benzotriazolyl, carbonylthio-pentafluorophenyl, 4-(carbonylthio)-N-methylpiperazinyl, 4-(carbonylthio),N,N-dimethylpiperazinium, 4-(carbonylthio)-morpholinyl, N,N-dimethylaminomethylcarbonylthio, trimethylammoniummethylcarbonylthio, 1-(thio)-bicyclo[2.2.1]heptyl, 4-(thio)-N-methylpiperadinyl,trimethylammoniumpropylthio, 5′-deoxy-adenosinyl-thio and acetonitrilethio.

14. The compound of claim 1 , with the proviso that at least one of R 4 , R 5 , R 6 , R 7 , and R 8 is not selected from the group consisting of hydrogen, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, alkenyl, polyalkenyl, alkynyl, polyalkynyl, alkenylalkynyl, aryl, heteroaryl, alkoxy, and dialkylamino, each of which may be optionally substituted; trimethylammoniumpropyl; amino; hydroxyl; N,N-dimethylpiperazinyl; pyrimidinylthio; a BRIDGE-DYE, and a reactive group, each of which optionally includes a quaternary ammonium moiety.

15. The compound of claim 1 , with the proviso that R 4 , R 5 , R 6 , and R 7 are not selected from the group consisting of halogen, cycloalkyl, alkenyl, polyalkenyl, alkynyl, polyalkynyl, alkenylalkynyl, alkoxy, and dialkylamino, each of which may be optionally substituted; a BRIDGE-DYE, and a reactive group, each of which optionally includes a quaternary ammonium moiety.

16. The compound of claim 1 , with the proviso that R 4 is not selected from the group consisting hydrogen, N,N-dimethylpiperazinyl, pyrimidinylthio, thiol, amino, and hydroxyl.

17. The compound of claim 1 , with the proviso that R 5 is not selected from the group consisting of trimethylammoniumpropyl and phenyl.

18. The compound of claim 1 , with the proviso that R 6 is not selected from the group consisting of hydrogen, methyl, and phenyl.

19. The compound of claim 1 , with the proviso that R 7 is not hydrogen.

20. The compound of claim 1 , having the formula:

wherein R 3 is hydrogen,and X, Y, R 2 , R 5 , and B are defined in the following table, with the proviso that the compound is not selected from the group consisting of dyes G5, H5, I5, K5, L5, D6, E6, P6, R6, Y6, Z6, F7, C8, E8, G8, L8, M8, N8, O8, and V8

Dye

Y

X

R 2

R 5

B

G5

S

Ph

H

H5

S

Me

H

I5

S

H

K5

S

Me

H

L5

S

Me

H

D6

S

Me

H

E6

O

Me

H

P6

S

H

R6

S

Me

H

Y6

O

Me

H

Z6

S

Me

H

F7

S

Me

Ph

2-[4-(N,N-dimethylpiperazine)]6-Me

C8

S

Me

Ph

2-NH 2 6-Me

E8

S

Me

Ph

2-OH6-Me

G8

S

Me

Ph

2-SCH 3 6-Me

L8

S

None

Ph

2-SCH 3 6-Me

M8

S

Me

Ph

2-[S-(2-pyrimidine)]6-Me

N8

S

Me

Ph

2-SMe6-Ph

O8

S

MeR 2 -C(O)Ph

H

V8

S

Me

Ph

2-SCH 3 6-Me

21. A compound having the formula:

wherein

the moiety  represents an optionally-substituted fused monocyclic or polycyclic aromatic ring or an optionally-substituted fused monocyclic or polycyclic nitrogen-containing heteroaromatic ring;

X is oxygen, sulfur, selenium, tellurium or a moiety selected from C(CH 3 ) 2 and NR 1 , where R 1 is hydrogen or C 1-6 alkyl;

R 2 is selected from the group consisting of C 1-6 alkyl, C 3-8 cycloalkyl, aryl, aryl(C 1-3 alkyl), hydroxyalkyl, alkoxyalkyl, aminoalkyl, mono and dialkylaminoalkyl, trialkylammoniumalkyl, alkylenecarboxylate, alkylenecarboxamide, alkylenesulfonate, optionally substituted cyclic heteroatom-containing moietics, and optionally substituted acyclic heteroatom-containing moieties;

t=0 or 1;

Z is a charge selected from 0 or 1;

R 3 is selected from the group consisting of hydrogen, C 1-6 alkyl, and arylcarbonyl, or R 2 and R 3 are taken together to form —(CH 2 ) w —, wherein w is 1 to 5;

R 9 and R 10 are each independently selected from the group consisting of hydrogen, C 1-5 alkyl, and arylcarbonyl;

n=0, 1, or 2; and

v=0 or 1; with the proviso that v=0 when R 2 and R 3 are not taken together to form —(CH 2 ) w —;

wherein when v=0, Q is an heterocycle selected from the group of structures consisting of:

and

wherein when v=1, Q is an heterocycle selected from the group of structures consisting of:

wherein R 4 , R 5 , R 6 , R 7 , R 8 , R 12 , and R 13 are independently selected from the group consisting of hydrogen, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, alkenyl, polyalkenyl, alkynyl, polyalkynyl, alkenylalkynyl, alkylnitrilethio, aryl, heteroaryl, alkoxy, alkylthio, arylcarbonylthio, cycloheteroalkylcarbonylthio, dialkylaminoalkylcarbonylthio, dialkylamino, cycloalkylthio, cycloheteroalkylthio, trialkylammoniumalkylthio, trialkylammoniumalkylcarbonylthio, and nucleosidylthio, each of which may be optionally substituted; an acyclic heteroatom-containing moiety, a cyclic heteroatom-containing moiety, a BRIDGE-DYE, and a reactive group, each of which optionally includes a quaternary ammonium moiety, and

wherein at least one of R 4 , R 5 ,R 6 , R 7 , and R 8 is selected from the group consisting of arylcarbonylthio, cycloheteroalkylcarbonylthio, dialkylaminoalkylcarbonylthio, trialkylammoniumalkylcarbonylthio, alkylnitrilethio, cycloalkylthio, cycloheteroalkylthio, trialkylammoniumalkylthio, and nucleosidylthio, each of which may be optionally substituted.

22. A compound having the formula:

wherein

the moiety  represents an optionally-substituted fused monocyclic or polycyclic aromatic ring or an optionally-substituted fused monocyclic or polycyclic nitrogen-containing heteroaromatic ring;

X is oxygen, sulfur, selenium, tellurium or a moiety selected from C(CH 3 ) 2 and NR 1 , where R 2 is hydrogen or C 1-6 alkyl;

R 2 is selected from the group consisting of C 1-6 alkyl, C 3-8 cycloalkyl, aryl, aryl(C 1-3 alkyl), hydroxyalkyl, alkoxyalkyl, aminoalkyl, mono and dialkylaminoalkyl, trialkylammoniumalkyl, alkylenecarboxylate, alkylenecarboxamide, alkylenesulfonate, optionally substituted cyclic heteroatom-containing moieties, and optionally substituted acyclic heteroatom-containing moieties;

t=0 or 1;

Z is a charge selected from 0 or 1;

R 3 is selected from the group consisting of hydrogen, C 1-6 alkyl, and arylcarbonyl, or R 2 and R 3 are taken together to form —(CH 2 ) w —, wherein w is 1 to 5;

R 9 and R 10 are each independently selected from the group consisting of hydrogen, C 1-6 alkyl, and arylcarbonyl;

n=0, 1, or 2; and

v=0 or 1; with the proviso that v=0 when R 2 and R 3 are not taken together to form —(CH 2 ) w—;

wherein when v=0, Q is an heterocycle selected from the group of structures consisting of:

and

wherein when v=1, Q is an heterocycle selected from the group of structures consisting of:

wherein R 4 , R 5 , R 6 , R 7 , R 8 , R 12 , and R 13 are independently selected from the group consisting of hydrogen, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, alkenyl, polyalkenyl, alkynyl, polyalkynl, alkenylalkynyl, alkylnitrilethio, aryl, heteroaryl, alkoxy, alkylthio, arylcarbonylthio, cycloheteroalkylcarbonylthio, dialkylaminoalkylcarbonylthio, dialkylamino, cycloalkylthio, cycloheteroalkylthio, trialkylammoniumalkylthio, trialkylammoniumalkylcarbonylthio, and nucleosidylthio, each of which may be optionally substituted; an acyclic heteroatom-containing moiety, a cyclic heteroatom-containing moiety, a BRIDGE-DYE, and a reactive group, each of which optionally includes a quaternary ammonium moiety, with the proviso that R 4 is not selected from the group consisting hydrogen, N,N-dimethylpiperazinyl, pyrimidinylthio, methylthio, thiol, amino, and hydroxyl.

Assignments (4)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS (RECORDED 9/5/12 AT REEL/FRAME 028914/0592) Recorded Dec 11, 2014
From: ATHYRIUM OPPORTUNITIES FUND (A) LP, AS ADMINISTRATIVE AGENT
To: BIOFIRE DIAGNOSTICS, INC.
Reel/Frame 034609/0944 →
CHANGE OF NAME Recorded Aug 19, 2014
From: IDAHO TECHNOLOGY, INC.
To: BIOFIRE DIAGNOSTICS, INC.
Reel/Frame 033568/0799 →
CHANGE OF NAME Recorded Aug 19, 2014
From: BIOFIRE DIAGNOSTICS, INC.
To: BIOFIRE DEFENSE, LLC
Reel/Frame 033568/0802 →
SECURITY AGREEMENT Recorded Sep 5, 2012
From: BIOFIRE DIAGNOSTICS, INC.
To: ATHYRIUM OPPORTUNITIES FUND (A) LP
Reel/Frame 028914/0592 →